Gene therapy treats "bubble boy disease," but raises leukemia risk

07/21/2010 | Reuters

A 10-year study showed that eight of nine boys with "bubble boy disease," or X-linked severe combined immunodeficiency disease, a rare ailment that keeps the body from developing mature T cells to ward off infections, were able to live normally after undergoing gene therapy. However, four of nine patients developed T-cell acute leukemia after receiving treatment. Three survived while one died.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA